Study subject and data collection.
We retrospectively investigated 421 patients who underwent a TV operation between 1994 and 2017 at Samsung Medical Center in Seoul, South Korea. We enrolled 158 patients who had significant TR with AF who underwent TV repair or replacement and CM procedure. Patients who did not have the CM procedure, did not have a follow-up ECG after three months post-op, or had inadequate echocardiographic measurements were not included. Patients were divided by recurrence of AF within 10 years after the TV operation with CM procedure (Figure 1).
The primary endpoint was AF recurrence. We analyzed the difference between the AF recurrence group vs. no recurrence groups, and analyzed the AF recurrence factor in terms of clinical and echocardiographic risk factors. Secondary end points were clinical outcomes in the two groups, which included death, TR recurrence, heart failure (HF) admission, permanent pacemaker (PPM) insertion and stroke events. The median clinical outcome follow-up duration was 7.9 years.
The medical records of the enrolled patients were carefully reviewed by research coordinators. Mortality data for patients who were lost to follow-up were confirmed by National Death Records. The study protocol was approved and the requirement for informed consent of the individual patients was waived by the Institutional Review Board of Samsung Medical Center. This study was conducted according to the principles of the Declaration of Helsinki. (IRB No. 2020-12-054)
Surgical technique.
Detailed techniques of the cryo-maze procedure were described in our previous report7. The cryo-maze procedure was performed with an N2O-based cryoprobe or an argon-based cryoprobe according to surgeons’ preference.
Usually, five lesions were created, including pulmonary vein isolation, mitral isthmus, posterior part of left atrium extending to the left atrial appendage to box the lesion, cavo-tricuspid-isthmus, and superior vena cava to inferior vena cava line. Ablation time was 180 seconds. After completion of this procedure, additional cardiac procedures including valve surgery, CABG, or ASD closures were performed. The opening left atrial appendage was internally obliterated without an excision using a running 3-0 monofilament suture.
Definitions
AF recurrence was defined as restoration of AF rhythm at least one time in follow up electrocardiography (ECG) more than three months after the operation. Patients who never returned to sinus rhythm were counted in the AF recurrence group and recurrence day was set as zero.
Structural heart disease (SHD) in this study was defined as more than a moderate degree of valve disease, previous cardiac operation history, or congenital heart such as like atrial septal defects (ASD). Isolated TR without SHD indicates secondary TR caused by atrial fibrillation. Significant VHD indicates more than a moderate degree of valve disease.
Chronic kidney disease was defined as a glomerular filtration rate (GFR) <60 mL/min/1.73 m2 over 3 months and a disease code in medical record. Coronary artery disease was defined as over 50% stenosis in at least one coronary artery on computed tomography (CT) angiography or coronary angiography. TR recurrence was defined as reappearance of more than a moderate degree of TR after restoration to a minimal or mild degree at early after surgery. Stroke was defined as a neurological deficit of abrupt onset caused by ischemia or hemorrhage within the brain.
Echocardiographic evaluation.
Two-dimensional echocardiography was performed using commercially available equipment (Vivid 7, GE Medical Systems, Milwaukee, WI; Acuson 512, Siemens Medical Solution, Mountain View, CA; or Sonos 5500, Philips Medical System, Andover, MA). End diastole was defined as the frame with the largest cavity area immediately before the onset of the QRS and end systole as the frame with the smallest cavity area. At rest, left ventricular end-diastolic dimension (LVEDD) and LV end-systolic dimension (LVESD) were obtained from parasternal views according to the American Society of Echocardiography (ASE) guidelines 8. LV ejection fraction (EF) were calculated from two-dimensional recordings using the modified biplane Simpson's method. Relative wall thickness (RWT) and left ventricular mass (LVM) were calculated from linear dimensions using the ASE-recommended formula. Left atrial (LA) volume was assessed by the modified biplane area-length method and was indexed to body surface area. Early diastolic mitral inflow velocity (E) was measured using the pulsed wave Doppler method by placing the sample volume at the level of the mitral valve leaflet tips. Tissue Doppler-derived early diastolic mitral annular velocity (e’) was measured from the septal corner of the mitral annulus in the apical four-chamber view. We calculated the E/e′ ratio as an index of left ventricular filling pressure. LA diameter was measured in the apical 4 chamber view or parasternal long axis view at end systole phase and LA diameter over 40mm was defined as LA enlargement (LAE). RA diameter was measure in a dedicated right heart view from an apical 4 chamber view that includes the entire RA and was not fore-shortened at the end ventricular systole phase from the inner edge to the inner edge at the mid-atrial level. Right ventricular (RV) diameter, Tricuspid annular plane systolic excursion (TAPSE), and TDI-derived tricuspid lateral annular systolic velocity (TV s’) were also measured in a dedicated right heart view. A RA diameter over 45mm was defined as RA enlargement (RAE). Right ventricular systolic pressure (RVSP) was obtained by assumed RA pressure plus 4 * (maximal TR velocity)2. RA pressure were assumed by Inferior vena cava (IVC) diameter and the presence of plethora. IVC diameter was measured at the junction of the hepatic vein approximately 3cm from the RA in a standard subcostal view at end expiration, perpendicular to the IVC long axis. Quantitative and qualitative measurements of TR severity were performed according to American Society of Echocardiography guidelines.
Statistical analysis.
Continuous variables are presented as mean ± standard deviation or median [interquartile range (IQR)]. Differences between the AF recurrence group and no AF recurrence group were evaluated using student t-test or Mann Whitney U test. Categorical variables were compared between groups using the Chi-square test or Fisher's exact test and are presented as numbers and relative frequencies (%).
Clinical factors were considered for old age (age over 60), Sex, DM, HTN, CKD, Stroke Hx, CAD, previous cardiac operation history, and TV operation method (TV repair or replacement). We also examined echo parameters including LVEF, LAVI, RAD, LVEDD, RVSP, E/e’, TR grade, and ASD closure. The univariable and multivariable Cox proportional hazard model was applied to estimate the hazard ratio (HR) and 95% confidence interval (CI) for AF recurrence. The survival curves were extracted using the Kaplan-Meier method. Variance inflation factors (VIF) of clinical factors ranged from 1.055 to 1.374. The VIFs of echo parameters ranged from 1.069 to 1.725. For clinical factors and echo parameters, the final multivariable regression model was determined by backward variable selection method with criteria of p-value<0.05. The C index or concordance C was considered an overall measure of discrimination in survival analysis, and we tested whether there was a difference between two correlated overall C indices. Cut-off values were determined by the slope and intercept value of a generalized linear model.
All p-values were two-sided, and p-values <0.05 were considered statistically significant. Statistical analyses were performed using R Statistical Software (version 3.6.0; R Foundation for Statistical Computing, Vienna, Austria) and SPSS statistics 20 (SPSS Inc., Chicago, IL).